FluticasoneSalmeterolQualityChecker
Fluticasone Salmeterol
Fluticasone Salmeterol Quality Checker — Combo Inhaler (ICS + LABA) (Ph. Eur., USP)
ℹ️ The utility checks content of both APIs, aerodynamics (FPF, MMAD), water, microbiology (incl. Pseudomonas).
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! FPF ≥30%, MMAD ≤5 µm, Water ≤1.0%, Absence of Pseudomonas/Staph!
Usage:
FluticasoneSalmeterolQualityChecker.exe → demo mode
FluticasoneSalmeterolQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,Fluticasone_Content_Percent,Salmeterol_Content_Percent,Fluticasone_Impurity_A_Percent,Fluticasone_Total_Impurities_Percent,Salmeterol_Impurity_A_Percent,Salmeterol_Total_Impurities_Percent,Total_All_Impurities_Percent,FPF_Fluticasone_Percent,FPF_Salmeterol_Percent,MMAD_Fluticasone_um,MMAD_Salmeterol_um,Delivered_Dose_Uniformity_RSD,Individual_Dose_Min_Percent,Individual_Dose_Max_Percent,Water_Content_Percent,Heavy_Metals_ppm,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected,Pseudomonas_Aeruginosa_Detected,Staphylococcus_Aureus_Detected
Example:
FLU-SAL-2026-001,98.5,99.2,0.15,0.4,0.2,0.5,0.8,42.0,40.0,3.2,3.4,8.5,88.0,112.0,0.6,5,20,5,0,0,0,0
— WHY IS THIS NEEDED?
Fluticasone (ICS) + Salmeterol (LABA) combination — gold standard for asthma and COPD therapy:
• Drug delivered directly to lungs, so particle size critical for both components
• Fine Particle Fraction (FPF) — fraction of particles < 5 µm capable of reaching alveoli. Low FPF = low efficacy
• MMAD (Mass Median Aerodynamic Diameter) — median aerodynamic diameter. Must be < 5 µm
• Dose Uniformity — each inhalation must contain exact dose of both substances. Variation unacceptable
• Water: For Dry Powder Inhalers (DPI), low moisture (<1%) is critical, otherwise powder clumps and fails to disperse
• Microbiology: Requirements stricter than tablets. Absence of Pseudomonas aeruginosa and Staphylococcus aureus mandatory (severe lung infections)
⚠️ CRITICAL:
• Content of both APIs: 90–110%
• FPF (for both): ≥ 30–40% (depends on delivery device)
• MMAD (for both): ≤ 5.0 µm
• Dose Uniformity: RSD ≤ 15%, individual dose range 75–125%
• Water: ≤ 1.0% (critical for powder stability)
• Microbiology: TAMC ≤ 100 CFU/g, TYMC ≤ 10 CFU/g, absence of E.Coli, Salmonella, Pseudomonas, Staph aureus
⚠️ Note: Utility accounts for inhalation form specifics. Aerodynamic parameters (FPF, MMAD) measured by cascade impactor. If particles too large, they deposit in oropharynx and do not reach lungs, causing side effects (thrush, dysphonia from steroid; tremor, tachycardia from agonist) without therapeutic effect. Water control critical to prevent powder agglomeration in capsule or blister.
input.csv
BatchNumber,Fluticasone_Content_Percent,Salmeterol_Content_Percent,Fluticasone_Impurity_A_Percent,Fluticasone_Total_Impurities_Percent,Salmeterol_Impurity_A_Percent,Salmeterol_Total_Impurities_Percent,Total_All_Impurities_Percent,FPF_Fluticasone_Percent,FPF_Salmeterol_Percent,MMAD_Fluticasone_um,MMAD_Salmeterol_um,Delivered_Dose_Uniformity_RSD,Individual_Dose_Min_Percent,Individual_Dose_Max_Percent,Water_Content_Percent,Heavy_Metals_ppm,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected,Pseudomonas_Aeruginosa_Detected,Staphylococcus_Aureus_Detected FLU-SAL-2026-001,98.5,99.2,0.15,0.4,0.2,0.5,0.8,42.0,40.0,3.2,3.4,8.5,88.0,112.0,0.6,5,20,5,0,0,0,0
URS & FS — user requirements and functional specification
This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.
1. Scope
The Fluticasone Salmeterol Quality Checker utility is used for Fluticasone Salmeterol. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.
The utility does not use machine learning; decisions are produced by deterministic rules.
Categories: Global API
Tags: API, assay, biosimilars, capsules, fixed-dose combinations, generics, impurities, market map, microbiology, solid dosage, uniformity, water quality
2. Execution modes
FluticasoneSalmeterolQualityChecker.exe → demo mode FluticasoneSalmeterolQualityChecker.exe input.csv output.json → evaluate data
3. Key controlled areas
- assay / content
- purity and impurities
- microbiology and pathogens
- heavy metals / elemental impurities
- pH and physicochemical parameters
4. Domain limits and critical parameters
- ⚠️ CRITICAL! FPF ≥30%, MMAD ≤5 µm, Water ≤1.0%, Absence of Pseudomonas/Staph!
- Fine Particle Fraction (FPF) — fraction of particles < 5 µm capable of reaching alveoli. Low FPF = low efficacy
- MMAD (Mass Median Aerodynamic Diameter) — median aerodynamic diameter. Must be < 5 µm
- Water: For Dry Powder Inhalers (DPI), low moisture (<1%) is critical, otherwise powder clumps and fails to disperse
- ⚠️ CRITICAL:
- Content of both APIs: 90–110%
- FPF (for both): ≥ 30–40% (depends on delivery device)
- MMAD (for both): ≤ 5.0 µm
- Dose Uniformity: RSD ≤ 15%, individual dose range 75–125%
- Water: ≤ 1.0% (critical for powder stability)
- Microbiology: TAMC ≤ 100 CFU/g, TYMC ≤ 10 CFU/g, absence of E.Coli, Salmonella, Pseudomonas, Staph aureus
- ⚠️ Note: Utility accounts for inhalation form specifics. Aerodynamic parameters (FPF, MMAD) measured by cascade impactor. If particles too large, they deposit in oropharynx and do not reach lungs, causing side effects (thrush, dysphonia from steroid; tremor, tachycardia from agonist) without therapeutic effect. Water control critical to prevent powder agglomeration in capsule or blister.
5. URS — user requirements
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The system shall accept an input.csv file for Fluticasone Salmeterol with the exact columns listed in the “Input data contract” section. | High | A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error. |
| URS-002 | The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data. | Medium | Both execution scenarios produce a predictable result or clear diagnostic error. |
| URS-003 | The system shall perform rule-based controls for: assay / content, purity and impurities, microbiology and pathogens, heavy metals / elemental impurities, pH and physicochemical parameters. | High | Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML. |
| URS-004 | The system shall preserve traceability between batch/lot, source values, applied rules and final verdict. | High | Output includes batch identifier, source values, parameter statuses and critical findings. |
| URS-005 | The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review. | High | JSON contains overall status, check array, warnings, failures and source-file reference. |
| URS-006 | The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks. | High | The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval. |
| URS-007 | The system shall clearly separate technical data errors from specification nonconformities. | Medium | Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately. |
6. input.csv data contract
The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.
| # | Column | Type | Unit | Description | Sample | Control rule |
|---|---|---|---|---|---|---|
| 1 | BatchNumber | identifier | as specified | Batch Number | FLU-SAL-2026-001 | mandatory field; used for batch/lot traceability |
| 2 | Fluticasone_Content_Percent | decimal | % | Fluticasone Content % | 98.5 | numeric value; compared with assay/purity limit from specification or method |
| 3 | Salmeterol_Content_Percent | decimal | % | Salmeterol Content % | 99.2 | numeric value; compared with assay/purity limit from specification or method |
| 4 | Fluticasone_Impurity_A_Percent | decimal | % | Fluticasone Impurity A % | 0.15 | numeric value; compared with individual or total impurity limit |
| 5 | Fluticasone_Total_Impurities_Percent | decimal | % | Fluticasone Total Impurities % | 0.4 | mandatory numeric value; rule comparison is performed by the utility |
| 6 | Salmeterol_Impurity_A_Percent | decimal | % | Salmeterol Impurity A % | 0.2 | numeric value; compared with individual or total impurity limit |
| 7 | Salmeterol_Total_Impurities_Percent | decimal | % | Salmeterol Total Impurities % | 0.5 | mandatory numeric value; rule comparison is performed by the utility |
| 8 | Total_All_Impurities_Percent | decimal | % | Total All Impurities % | 0.8 | mandatory numeric value; rule comparison is performed by the utility |
| 9 | FPF_Fluticasone_Percent | decimal | % | FPF Fluticasone % | 42.0 | mandatory numeric value; rule comparison is performed by the utility |
| 10 | FPF_Salmeterol_Percent | decimal | % | FPF Salmeterol % | 40.0 | mandatory numeric value; rule comparison is performed by the utility |
| 11 | MMAD_Fluticasone_um | decimal | µm | MMAD Fluticasone um | 3.2 | mandatory numeric value; rule comparison is performed by the utility |
| 12 | MMAD_Salmeterol_um | decimal | µm | MMAD Salmeterol um | 3.4 | mandatory numeric value; rule comparison is performed by the utility |
| 13 | Delivered_Dose_Uniformity_RSD | decimal | as specified | Delivered Dose Uniformity RSD | 8.5 | mandatory numeric value; rule comparison is performed by the utility |
| 14 | Individual_Dose_Min_Percent | decimal | % | Individual Dose Min % | 88.0 | mandatory numeric value; rule comparison is performed by the utility |
| 15 | Individual_Dose_Max_Percent | decimal | % | Individual Dose Max % | 112.0 | mandatory numeric value; rule comparison is performed by the utility |
| 16 | Water_Content_Percent | decimal | % | Water Content % | 0.6 | numeric value; compared with assay/purity limit from specification or method |
| 17 | Heavy_Metals_ppm | decimal | ppm | Heavy Metals ppm | 5 | numeric value; checked as elemental/metal impurity |
| 18 | Microbial_Count_TAMC | decimal | as specified | Microbial Count TAMC | 20 | numeric value; compared with microbiological limits |
| 19 | Microbial_Count_TYMC | decimal | as specified | Microbial Count TYMC | 5 | numeric value; compared with microbiological limits |
| 20 | EColi_Detected | boolean / flag | 0/1 | EColi Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 21 | Salmonella_Detected | boolean / flag | 0/1 | Salmonella Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 22 | Pseudomonas_Aeruginosa_Detected | boolean / flag | 0/1 | Pseudomonas Aeruginosa Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 23 | Staphylococcus_Aureus_Detected | boolean / flag | 0/1 | Staphylococcus Aureus Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
CSV example
BatchNumber,Fluticasone_Content_Percent,Salmeterol_Content_Percent,Fluticasone_Impurity_A_Percent,Fluticasone_Total_Impurities_Percent,Salmeterol_Impurity_A_Percent,Salmeterol_Total_Impurities_Percent,Total_All_Impurities_Percent,FPF_Fluticasone_Percent,FPF_Salmeterol_Percent,MMAD_Fluticasone_um,MMAD_Salmeterol_um,Delivered_Dose_Uniformity_RSD,Individual_Dose_Min_Percent,Individual_Dose_Max_Percent,Water_Content_Percent,Heavy_Metals_ppm,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected,Pseudomonas_Aeruginosa_Detected,Staphylococcus_Aureus_Detected FLU-SAL-2026-001,98.5,99.2,0.15,0.4,0.2,0.5,0.8,42.0,40.0,3.2,3.4,8.5,88.0,112.0,0.6,5,20,5,0,0,0,0
7. FS — functional specification
| ID | Function | Implementation description |
|---|---|---|
| FS-001 | CLI entry point | The executable FluticasoneSalmeterolQualityChecker.exe supports demo mode and input.csv output.json processing mode. |
| FS-002 | CSV parser | The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator. |
| FS-003 | Field conversion | Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag. |
| FS-004 | Domain rule engine | For Fluticasone Salmeterol, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check. |
| FS-005 | Criticality handling | Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS. |
| FS-006 | JSON writer | output.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages. |
| FS-007 | Integration contract | The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service. |
| FS-008 | Error handling | Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS. |
8. output.json contract
The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.
{
"utility": "FluticasoneSalmeterolQualityChecker",
"api": "Fluticasone Salmeterol",
"batchNumber": "FLU-SAL-2026-001",
"overallStatus": "PASS|WARNING|FAIL",
"checkedAtUtc": "2026-05-18T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "FLU-SAL-2026-001",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Fluticasone_Content_Percent",
"value": "98.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Salmeterol_Content_Percent",
"value": "99.2",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Fluticasone_Impurity_A_Percent",
"value": "0.15",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Fluticasone_Total_Impurities_Percent",
"value": "0.4",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Salmeterol_Impurity_A_Percent",
"value": "0.2",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Salmeterol_Total_Impurities_Percent",
"value": "0.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Total_All_Impurities_Percent",
"value": "0.8",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"sourceFile": "input.csv"
}9. OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| TC-001 | Valid CSV with expected header and sample row | All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail. |
| TC-002 | A mandatory input.csv column is missing | Import is rejected or the row receives FAIL with schema reference. |
| TC-003 | A numeric field contains text or a blank value | Type conversion error is recorded; the result is not hidden as PASS. |
| TC-004 | A parameter is outside specification or critical limit | Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule. |
| TC-005 | Positive pathogen/microbiological flag or microbiological limit excursion | Critical FAIL is produced with the offending parameter. |
10. QA/QC, CSV and change control
- Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
- Column names must not be changed without updating the validator and test scenarios.
- The source CSV, output.json and utility version should be stored together as an evidence package.
- Any change in control rules must go through change control and repeated OQ scenario verification.
Included in packages
Algeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenArgentina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenAustralia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBangladesh: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBrazil: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenCanada: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenChina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenColombia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenDemocratic Republic of the Congo: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenEgypt: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenENT QC Suite
QC package for ENT: nasal sprays, ear drops, local antiseptics, corticosteroids, antibiotics and upper-airway medicines.
OpenEthiopia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenFrance: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGermany: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGlobal API & Biosimilars QC Suite
Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.
OpenIndia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIndonesia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIran: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenItaly: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenJapan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenKenya: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMexico: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMyanmar: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenNigeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPakistan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPhilippines: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenRussia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSaudi Arabia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Africa: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Korea: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSudan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTanzania: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenThailand: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTurkey: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUganda: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited Kingdom: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited States: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenVietnam: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Open